Announcements Trials
Browse Landscape

Status

Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Interventional 48Observational 10Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 28Carcinoma, Renal Cell 7Pancreatic Neoplasms 6Ovarian Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Sarcoma 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 3Melanoma 3Stomach Neoplasms 2Rhabdoid Tumor 2Prostatic Neoplasms, Castration-Resistant 2Head and Neck Neoplasms 2Glioblastoma 2Chondrosarcoma 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Wilms Tumor 1Urologic Neoplasms 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prostatic Diseases 1

Interventions

gallium 68 PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Prostatic Diseases × Genitourinary × Clear all
NCT04452136 2022-03-14

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

OHSU Knight Cancer Institute

Approved for marketing
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡